Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies. Gurusamy D, Henning AN, Yamamoto TN, Yu Z, et al. Cancer Cell 2020;37:818-833.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gurusamy D, Henning AN, Yamamoto TN, Yu Z, et al. Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies. Cancer Cell 2020;37:818-833.
PMID: 32516591